PHA Classroom: e-Learning. Anytime. Anyplace.


>>Back to All Recordings

>>Back to About PH Recordings
>>Back to 2012 Conference Session Recordings

Session Recording from PHA's 2012 10th International PH Conference
Combination Treatments in PAH: When and Why

June 23, 2012

Treatment options for pulmonary hypertension have dramatically expanded with the availability of multiple medications. If one treatment is good, are two better? When should medication be adjusted or switched, and what evidence is available to guide therapy? This session will focus on the rationale for combination therapy and review results of studies of combination therapy.

Presenter Information

Nicholas Hill, MD, Tufts University School of Medicine, Boston, Mass. (Chair); Harold Palevsky, MD, Penn Presbyterian Medical Center, Philadelphia, Pa.; Ioana Preston, MD, Tufts Medical Center, Boston, Mass.; Jeffrey Sager, MD, MSc, FCCP, Santa Barbara Pulmonary Consultants, Santa Barbara, Calif.

 

 

 

DIAMOND
SUPPORTER

PLATINUM
SUPPORTER

GOLD
SUPPORTER

SILVER
SUPPORTER

Actelion Pharmaceuticals US, Inc. Gilead Sciences, Inc. United Therapeutics Corporation Bayer HealthCare
This is a program of the PHA Medical Education Fund, made possible through unrestricted educational grants from our supporters.

 

The information provided on the PHA website is provided for general information only. It is not intended as legal, medical or other professional advice, and should not be relied upon as a substitute for consultations with qualified professionals who are familiar with your individual needs.

801 Roeder Road, Ste. 1000, Silver Spring, MD 20910   Patient-to-Patient Support Line: 1-800-748-7274
Webmaster@PHAssociation.org
    Privacy Policy   Virtual Tour of Website    Provide Feedback & Report Bugs

Designed by Matrix Group International, Inc.® | © 2014 Pulmonary Hypertension Association. All Rights Reserved.

NORD

The National Organization for Rare Disorders (NORD) awarded PHA the Abbey S. Meyers Leadership Award in 2012 for outstanding service to PHA members in advocacy, education and other key areas.